AC Immune ACIU
NASDAQ ACIU
$2.84 -0.10 (-3.25%)
As of: Sep 4, 2026 · 3:00 PM EDT

AC Immune (ACIU) Other Non Operating Income (2016 - 2026)

AC Immune (ACIU) posted quarterly Other Non Operating Income of -$224752.8 for Q1 2026, up 30.8% year-over-year from -$171832.2 in Q1 2025, and up 38.06% quarter-over-quarter from -$362839.2 in Q4 2025.

Analysis

AC Immune (ACIU) Other Non Operating Income (2016 - 2026) Analysis & Trends

AC Immune (ACIU) has reported Other Non Operating Income for 11 consecutive years, with -$224752.8 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Non Operating Income rose 30.8% year-over-year to -$224752.8; the TTM figure through Mar 2026 stood at -$3.3 million (up 16.87% YoY), while the FY2025 annual figure was -$3.4 million, down 85.33% from the prior year.
  • Other Non Operating Income climbed to -$224752.8 in Q1 2026 per ACIU's latest filing, from -$362839.2 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2.2 million in Q4 2024 and bottomed at -$3.1 million in Q3 2024.
  • Historically, Other Non Operating Income has averaged -$354599.2 across 5 years, with a median of -$55139.3 in 2023.
  • On a YoY basis, Other Non Operating Income climbed as much as 3451.49% in 2024 and fell as far as 15460.19% in 2024.
  • AC Immune's Other Non Operating Income stood at -$113144.4 in 2022, then slumped by 861.51% to -$1.1 million in 2023, then jumped by 306.19% to $2.2 million in 2024, then sank by 116.18% to -$362839.2 in 2025, then jumped by 38.06% to -$224752.8 in 2026.
  • Business Quant data shows ACIU's Other Non Operating Income at -$224752.8 in Q1 2026, -$362839.2 in Q4 2025, and -$15001.3 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 AC Immune 285.63 Mn 285.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 722,451.53
Mar 31, 2026 -224,752.82
Dec 31, 2025 -362,839.24
Sep 30, 2025 -15,001.31
Jun 30, 2025 -2.67 Mn
Mar 31, 2025 -324,777.16
Dec 31, 2024 2.24 Mn
Sep 30, 2024 -3.08 Mn
Jun 30, 2024 -2.77 Mn
Mar 31, 2024 1.85 Mn
Dec 31, 2023 -1.24 Mn
Sep 30, 2023 75,854.22
Jun 30, 2023 -17,794.81
Mar 31, 2023 -55,139.29
Dec 31, 2022 -113,144.39
Sep 30, 2022 17,602.76
Jun 30, 2022 358,211.09
Mar 31, 2022 151,593.17
Dec 31, 2021 -405,603.78
Sep 30, 2021 132,873.75